Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1157P is a pseudogene derived from the U6 small nuclear RNA gene family, present in the human genome as a result of retrotransposition and genome duplication events[5]. Unlike the canonical U6 small nuclear RNA—which plays an essential role in the spliceosome, catalyzing the removal of introns from pre-mRNA[1][3]—RNU6-1157P does not encode a functional RNA and is not incorporated into the spliceosome[5]. The formation of such pseudogenes is largely due to LINE-1 retrotransposition machinery, and they serve as markers for genome evolution dynamics but lack direct biological, disease, or therapeutic relevance[5]. There are no drugs, disease associations, or clinical markers linked to this specific pseudogene[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1157, pseudogene (RNU6-1157P).